Interferon-alpha-induced changes in metallothionein expression in liver biopsies from patients with chronic hepatitis C

Canadian Journal of Gastroenterology

Volumn 19, Issue 8, 2005, Pages 481-486

  Nagamine, Takeaki ^a   Suzuki, Keiji ^a   Kondo, Toshihiko ^a   Nakazato, Kyoumi ^a   Kakizaki, Satoru ^a   Takagi, Hitoshi ^a   Nakajima, Katsuyuki ^b  

^a GUNMA UNIVERSITY   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

Author keywords

Chronic hepatitis C; Interferon alpha; Knodell histological activity index score; Metallothionein; PCNA labelling index

Indexed keywords

ALPHA INTERFERON; CYCLINE; MESSENGER RNA; METALLOTHIONEIN; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER BIOPSY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 24644520985     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/262597     Document Type: Article

References (46)

1. Alter HJ, Seeff LB. Recovery, persistence, and sequel in hepatitis C virus infection: A perspective on long-term outcome. Semin Liver Dis 2000;20:17-35.
2. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 2000;132:296-305.
3. Mahmood S, Kawanaka M, Kamei A, et al. Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxid Redox Signal 2004;6:19-24.
4. Lai MM. Hepatitis C virus proteins: Direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology 2002;122:568-70.
5. De Maria N, Colantoni A, Fagiuoli S, et al. Association between oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 1996;21:291-5.
6. Paradis V, Mathurin P, Kollinger M, et al. In situ detection of lipid peroxidation in chronic hepatitis C: Correlation with pathological features. J Clin Pathol 1997;50:401-6.
7. Valgimigli M, Valgimigli L, Trere D, et al. Oxidative stress EPR measurement in human liver by radical probe technique. Correlation with etiology, histology and cell proliferation. Free Radic Res 2002;36:939-48.
8. Bureau C, Bernad J, Chauche N, et al. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem 2001;22:23077-83.
9. Gong G. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci USA 2001;98:9599-604.
10. Okuda M, Li M, Beard MR, et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002;122:366-75.
11. Moriya K, Nakagawa K, Santa T, et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 2001;61:4365-70.
12. Sakurai A, Hara S, Okano N, Kondo Y, Inoue J, Imura N. Regulatory role of metallothionein in NF-kappa B activation. FEBS Lett 1999;455:55-8.
13. Papouli E, Defais M, Larminat F. Over expression of metallothionein-II sensitizes rodent cells to apoptosis induced by DNA cross-linking agent through inhibition of NF-κB activation. J Biol Chem 2002;277:4764-9.
14. Choi J, Lee KJ, Zheng Y, Yamaga AK, Lai MM, Ou JH. Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology 2004;39:81-9.
15. Cousins RJ. Absorption, transport and hepatic metabolism of copper and zinc: Special reference to metallothionein and ceruloplasmin. Physiol Rev 1985;65:238-309.
16. Waalkes M, Goering PL. Metallothionein and other cadmium-binding proteins: Recent developments. Chem Res Toxicol 1990;3:281-8.
17. Sato M, Bremner I. Oxygen free radicals and metallothionein. Free Radic Biol Med 1993;14:25-37.
18. Thornalley PJ, Vasak M. Possible role for metallothionein in protection against radiation-induced oxidative stress. Biochim Biophys Acta 1985;827:36-44.
19. Li TY, Kraker AJ, Shaw CF, Petering DH. Ligand substitution reactions of metallothionein with EDTA and apo-carbonic anhydrase. Proc Natl Acad Sci USA 1980;77:6334-8.
20. Kumari MV, Hiramatu M, Ebadi M. Free radical scavenging actions of metallothionein isoforms I and II. Free Radic Res 1998;29:93-101.
21. Palmiter RD. Metallothionein facts and frustrations. In: Klaassen CD, ed. Metallothionein IV. Basel: Birkhauser Verlag, 1999:215-21.
22. Schroeder JJ, Cousins RJ. Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. Proc Natl Acad Sci USA 1990;87:3137-41.
23. Cherian MG, Chan HM. Biological functions of metallothionein - A review. In: Suzuki KT, Imura N, Kimura M, eds. Metallothionein III. Basel: Birkhauser Verlag, 1993:87-109.
24. Andrews GK. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol 2000;59:95-104.
25. David SR, Cousins RJ. Metallothionein expression in animals: A physiological perspective on function. J Nutr 2000;130:1085-8.
26. Palmiter RD. Regulation of metallothionein genes by heavy metals appears to be mediated by a zinc-sensitive inhibitor that interacts with a constitutively active transcription factor, MTF- 1. Proc Natl Acad Sci USA 1994;91:1219-23.
27. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001;358:958-65.
28. Fried MW, Shiffman ML, Reddy R, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-82.
29. Trepo C. Genotype and viral load as prognostic indicators in the treatment of hepatitis C. J Viral Hepat 2000;7:250-7.
30. Gao B, Hong F, Radaeva S. Host factors and failure of interferon-alpha treatment in hepatitis C virus. Hepatology 2004;39:39880-90.
31. Friedman RL, Stark GR. alpha-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences. Nature 1985;314:637-9.
32. Sciavolino PJ, Vilcek J. Regulation of metallothionein gene expression by TNF-alpha and IFN-beta in human fibroblasts. Cytokine 1995;7:242-50.
33. Carrera G, Paternain JL, Carrera N, et al. Hepatic metallothionein in patients with chronic hepatitis C: Relationship with severity of liver disease and response to treatment. Am J Gastroenterology 2003;98:1142-9.
34. Nagamine T, Takagi H, Hashimoto Y, et al. The possible role of zinc and metallothionein in the liver on the therapeutic effect of interferon-alpha to hepatitis C patients. Biol Trace Elem Res 1997;58:65-76.
35. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
36. Nakajima K, Suzuki K, Otaki N, Kimura M. Detection of MT in brain. In: Riordan JF, Valle BL, eds. Methods in Enzymology Vol 205, Metallobiochemistry, Part B. San Diego: Academic Press, 1991:387-95.
37. Kubota S, Takabe Y, Kubota S, Takabe Y. [Detection of gene expression using digoxigenin-labeled probes]. Tanpakushitsu Kakusan Koso 1996;41:486-90.
38. Haas CJ, Hirschmann A, Sendelhofert A, Diebold J, Arnholdt H, Lohrs U. Improvement of nonradioactive DNA in situ hybridization. Biotech Histochem 1998;73:228-32.
39. Goulding H, Jasani B, Pereira H, et al. Metallothionein expression in human breast cancer. Br J Cancer 1995;72:968-72.
40. Endo T, Yoshikawa M, Ebara M, et al. Immunchistochemical metallothionein expression in hepatocellular carcinoma: Relation to tumor progression and chemoresistance to platinum agents. J Gastroenterol 2004;39:1196-201.
41. Tanimoto K, Akbar SM, Yamauchi Y, Michitaka K, Horiike N, Onji M. Immunohistochemical localization of metallothionein in hepatocellular carcinoma: Preferential expression in non-cancerous cirrhotic nodules. Oncol Rep 1998;5:805-9.
42. Koziel MJ, Dudley D, Afdhal N, et al. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 1995;96:2311-21.
43. Bertoletti A, D'Elios MM, Boni C, et al. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997;112:193-9.
44. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity. Hepatology 1997;25:449-58.
45. Marinho RT, Pinto R, Santos ML, Lobos IV, Moura MC. Effects of interferon and ribavirin combination therapy on CD4+ proliferation, lymphocyte activation, and Th1 and Th2 cytokine profiles in chronic hepatitis C. J Viral Hepat 2004;11:206-16.
46. Sato M, Yamaki J, Oguro T, Yoshida T, Nomura N, Nakajima K. Metallothionein synthesis induced by interferon alpha/beta in mice of various zinc status. Tohoku J Exp Med 1996;178:241-50.